The Prostate is a peer-reviewed journal dedicated to original studies of this organ and the male accessory glands. It serves as an international medium for these studies, presenting comprehensive coverage of clinical, anatomic, embryologic, physiologic, endocrinologic, and biochemical studies.
Tumor‐infiltrating mesenchymal stem cells: Drivers of the immunosuppressive tumor microenvironment in prostate cancer?
来源期刊：The ProstateDOI：10.1002/pros.23738
The association of BRCA1 and \nBRCA2 mutations with prostate cancer risk, frequency, and mortality: A meta‐analysis
来源期刊：The ProstateDOI：10.1002/pros.23795
Standardization of CTC AR‐V7 PCR assay and evaluation of its role in castration resistant prostate cancer progression
来源期刊：The ProstateDOI：10.1002/pros.23710
PTEN‐deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells
来源期刊：The ProstateDOI：10.1002/pros.23808
Consequences of interleukin 1β‐triggered chronic inflammation in the mouse prostate gland: Altered architecture associated with prolonged CD4+ infiltration mimics human proliferative inflammatory atrophy
来源期刊：The ProstateDOI：10.1002/pros.23784
Omega‐3 fatty acids decrease prostate cancer progression associated with an anti‐tumor immune response in eugonadal and castrated mice
来源期刊：The ProstateDOI：10.1002/pros.23706
An exploratory retrospective multicenter study of prognostic factors in mCRPC patients undergoing enzalutamide treatment: Focus on early PSA decline and kinetics at time of progression
来源期刊：The ProstateDOI：10.1002/pros.23865
Infiltrating CD4+ T cells attenuate chemotherapy sensitivity in prostate cancer via CCL5 signaling
来源期刊：The ProstateDOI：10.1002/pros.23810
Targeting prosurvival BCL2 signaling through Akt blockade sensitizes castration‐resistant prostate cancer cells to enzalutamide
来源期刊：The ProstateDOI：10.1002/pros.23843
Increased EZH2 expression in prostate cancer is associated with metastatic recurrence following external beam radiotherapy
来源期刊：The ProstateDOI：10.1002/pros.23817
Plasma extracellular vesicles as phenotypic biomarkers in prostate cancer patients
来源期刊：The ProstateDOI：10.1002/pros.23901
CUL4B/miR‐33b/C‐MYC axis promotes prostate cancer progression
来源期刊：The ProstateDOI：10.1002/pros.23754
Targeting the TMPRSS2/ERG fusion mRNA using liposomal nanovectors enhances docetaxel treatment in prostate cancer
来源期刊：The ProstateDOI：10.1002/pros.23918
Comparison of preoperative locoregional Ga‐68 PSMA‐11 PET‐CT and mp‐MRI results with postoperative histopathology of prostate cancer
来源期刊：The ProstateDOI：10.1002/pros.23812
Clinical effectiveness of docetaxel for castration‐sensitive prostate cancer in a real‐world population‐based analysis
来源期刊：The ProstateDOI：10.1002/pros.23733
The stem cell inhibitor salinomycin decreases colony formation potential and tumor‐initiating population in docetaxel‐sensitive and docetaxel‐resistant prostate cancer cells
来源期刊：The ProstateDOI：10.1002/pros.23940
Concept and benchmarks for assessing narrow‐sense validity of genetic risk score values
来源期刊：The ProstateDOI：10.1002/pros.23821
Circulating microRNAs in plasma among men with low‐grade and high‐grade prostate cancer at prostate biopsy
来源期刊：The ProstateDOI：10.1002/pros.23803
Sex steroids in serum and prostatic tissue of human cancerous prostate (STERKPROSER trial)
来源期刊：The ProstateDOI：10.1002/pros.23732
Trichomonas vaginalis infection and prostate‐specific antigen concentration: Insights into prostate involvement and prostate disease risk
来源期刊：The ProstateDOI：10.1002/pros.23886
Identification of targets for prostate cancer immunotherapy
来源期刊：The ProstateDOI：10.1002/pros.23756
Activation of cGMP/PKG/p65 signaling associated with PDE5‐Is downregulates CCL5 secretion by CD8 + T cells in benign prostatic hyperplasia
来源期刊：The ProstateDOI：10.1002/pros.23801
Testosterone accumulation in prostate cancer cells is enhanced by facilitated diffusion
来源期刊：The ProstateDOI：10.1002/pros.23874
The metastasis suppressor CD82/KAI1 represses the TGF‐β\n1 and Wnt signalings inducing epithelial‐to‐mesenchymal transition linked to invasiveness of prostate cancer cells
来源期刊：The ProstateDOI：10.1002/pros.23837
Correlation between cribriform/intraductal prostatic adenocarcinoma and percent Gleason pattern 4 to a 22‐gene genomic classifier
来源期刊：The ProstateDOI：10.1002/pros.23926
PEOPLE: PatiEnt prOstate samPLes for rEsearch, a tissue collection pathway utilizing magnetic resonance imaging data to target tumor and benign tissue in fresh radical prostatectomy specimens
来源期刊：The ProstateDOI：10.1002/pros.23782
Clonal evaluation of early onset prostate cancer by expression profiling of ERG, SPINK1, ETV1, and ETV4 on whole‐mount radical prostatectomy tissue
来源期刊：The ProstateDOI：10.1002/pros.23914
Inhibiting geranylgeranyl diphosphate synthesis reduces nuclear androgen receptor signaling and neuroendocrine differentiation in prostate cancer cell models
来源期刊：The ProstateDOI：10.1002/pros.23707
Cigarette smoking augments androgen receptor activity and promotes resistance to antiandrogen therapy
来源期刊：The ProstateDOI：10.1002/pros.23828
HOXA10 expression profiling in prostate cancer
来源期刊：The ProstateDOI：10.1002/pros.23761
Circulating inflammation markers and prostate cancer
来源期刊：The ProstateDOI：10.1002/pros.23842
Re‐treatment with radium‐223: 2‐year follow‐up from an international, open‐label, phase 1/2 study in patients with castration‐resistant prostate cancer and bone metastases
来源期刊：The ProstateDOI：10.1002/pros.23893
Incidence of androgen receptor and androgen receptor variant 7 coexpression in prostate cancer
来源期刊：The ProstateDOI：10.1002/pros.23906
Characterization of glycine‐N‐acyltransferase like 1 (GLYATL1) in prostate cancer
来源期刊：The ProstateDOI：10.1002/pros.23887
The expression profile and heterogeneity analysis of ERG in 633 consecutive prostate cancers from a single center
来源期刊：The ProstateDOI：10.1002/pros.23785
Does ductal adenocarcinoma of the prostate (DA) have any prognostic impact on patients with de novo metastatic prostate cancer?
来源期刊：The ProstateDOI：10.1002/pros.23892
DHX15 is up‐regulated in castration‐resistant prostate cancer and required for androgen receptor sensitivity to low DHT concentrations
来源期刊：The ProstateDOI：10.1002/pros.23773
Prostate cancer research: The next generation; report from the 2019 Coffey‐Holden Prostate Cancer Academy Meeting
来源期刊：The ProstateDOI：10.1002/pros.23934
A folic acid‐enriched diet attenuates prostate involution in response to androgen deprivation
来源期刊：The ProstateDOI：10.1002/pros.23723
TRPV1 in experimental autoimmune prostatitis
来源期刊：The ProstateDOI：10.1002/pros.23913
Grade groups at diagnosis in African Caribbean men with prostate cancer: Results of a comparative study
来源期刊：The ProstateDOI：10.1002/pros.23888
Osajin displays potential antiprostate cancer efficacy via impairment of fatty acid synthase and androgen receptor expression
来源期刊：The ProstateDOI：10.1002/pros.23876
A novel androgen receptor antagonist JJ‐450 inhibits enzalutamide‐resistant mutant ARF876L nuclear import and function
来源期刊：The ProstateDOI：10.1002/pros.23945
Germline BLM mutations and metastatic prostate cancer
来源期刊：The ProstateDOI：10.1002/pros.23924
Dihydrotestosterone inhibits arylsulfatase B and Dickkopf Wnt signaling pathway inhibitor (DKK)‐3 leading to enhanced Wnt signaling in prostate epithelium in response to stromal Wnt3A
来源期刊：The ProstateDOI：10.1002/pros.23776
RNA‐based markers in biopsy cores with atypical small acinar proliferation: Predictive effect of T2E fusion positivity and MMP‐2 upregulation for a subsequent prostate cancer diagnosis
来源期刊：The ProstateDOI：10.1002/pros.23724
Optimizing live‐animal bioluminescence imaging prediction of tumor burden in human prostate cancer xenograft models in SCID‐NSG mice
来源期刊：The ProstateDOI：10.1002/pros.23802
Protein kinase D1 induces G1‐phase cell‐cycle arrest independent of Checkpoint kinases by phosphorylating Cell Division Cycle Phosphatase 25
来源期刊：The ProstateDOI：10.1002/pros.23807
No survival benefit found after extended treatment with docetaxel for patients with castration‐resistant prostate cancer
来源期刊：The ProstateDOI：10.1002/pros.23884
Tyrosine kinase inhibitor therapy prescribed for non‐urologic diseases can modify PSA titers in urology patients
来源期刊：The ProstateDOI：10.1002/pros.23730
